Manforce condom maker (Mankind) shares list at 20% premium over IPO price

The initial public offering (IPO) price has been set at Rs 1,080.

At the close, the IPO received a total subscription of 15.32 times the offered shares.

Mankind Pharma (MANKIND) shares had an impressive market debut on Tuesday, May 9.

The shares of Mankind Pharma opened at a premium of 20.37% above the issue price, at Rs 1,300 per share.

With a value of Rs 4,326 crore, this IPO is one of the largest by a domestic pharmaceutical company since Gland Pharma's Rs 6,480 crore IPO in 2020 and the largest of 2023 thus far.

WATCH MORE STORIES